arthritis systemic inflammatory diseases
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - patients with clinically suspected arthralgia or a diagnosis of an immune-mediated inflammatory disease - patients must be 18 years or older
Exclusion criteria
Exclusion criteria: - patients unable to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify immunological alterations in the PB and SF of patients with various forms of established or early forms of immune-mediated inflammatory diseases and to correlate these alterations with diagnosis, disease stage, prognosis, and treatment response and compare this to healthy controls. We thereby aim to identify and validate novel biomarkers that can be used for personalized medicine in IMIDs | — |
Secondary
| Measure | Time frame |
|---|---|
| n.a. | — |
Countries
Netherlands
Outcome results
None listed